Oh, okay, sorry, I misread. Yeah, we are close to

Oh, okay, sorry, I misread. Yeah, we are close to the same page then. And I will say, NP has gotten Cytodyn to a point with the science that after the BLA submission, I would not be concerned with another CEO taking over. And I agree another CEO might have been able to have managed the share price. One of the biggest mistakes I believe with funding was in 2016 with Charlie Sheen promoting the drug, spiking the share price as high at $1.50, giving paulson 75c warrants plus unrestricted shares, with the share price over $1. It gapped down and has never recovered, it has been in a downtrend ever since, because it has been cycle repeat with that type of funding.